Clinical Trial Update: Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention [Phase 3]

View source ↗

Summary

A Phase 3 trial is planned to evaluate empagliflozin (EMPAgliflozin) with personalized dietary counseling for preventing kidney stones. The study is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Stones
• Nephrolithiasis

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Kidney Stone, Nephrolithiasis | Phase 3 | Status: NOT_YET_RECRUITING